Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07038005
PHASE1

A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.

View on ClinicalTrials.gov

Summary

This study includes two cohorts, respectively evaluating safety, tolerability and preliminary efficacy of intravenous and subcutaneous administration of SPGL008.

Official title: A Phase I Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SPGL008 Monotherapy for Patients With Advanced Malignant Tumors

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

96

Start Date

2025-07-30

Completion Date

2027-06-08

Last Updated

2026-02-09

Healthy Volunteers

No

Interventions

DRUG

SPGL008

Biological product

Locations (1)

Chongqing University Cancer Hospital

Chongqing, Chongqing Municipality, China